Xingyao Technology

PharmaceuticalsSeries ABeijing, Chinagalixir.com

Latest round

Series A

Last raised

Dec 2020

Total raised

Undisclosed

Investors

6

About Xingyao Technology

Established in 2019 and based in Shenzhen, China, Xingyao Technology is a company that empowers drug research and development through artificial intelligence technology. It is a participant of Merck China Innovation Hub. The company mainly operates an artificial intelligence drug discovery platform, Pyxir™, which combines expertise in computational chemistry and medicinal chemistry. The platform includes modules such as molecular design, attribute prediction, virtual screening, and targeted optimization, providing coverage from target development to clinical full-process service of former drug candidate discovery.

Who invested in Xingyao Technology

6 investors across 2 rounds

See all investors in Xingyao Technology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 29, 2020

    Amount

    Undisclosed

    Investors

    Locked

  2. Angel

    Jul 12, 2019

    Amount

    Undisclosed

    Investors

    Locked

Questions about Xingyao Technology

Who invested in Xingyao Technology?

Xingyao Technology has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Xingyao Technology raised?

Xingyao Technology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Xingyao Technology last raise money?

Xingyao Technology's most recent round on record is a Series A, in Dec 2020.

What does Xingyao Technology do?

Established in 2019 and based in Shenzhen, China, Xingyao Technology is a company that empowers drug research and development through artificial intelligence technology.

Where is Xingyao Technology headquartered?

Xingyao Technology is headquartered in Beijing, China.

Which VCs invest in companies like Xingyao Technology?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Xingyao Technology's stage. Their profiles are linked below.

Raising like Xingyao Technology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.